Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Ziegler

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
Advanced Drug Delivery Reviews|March 17, 2023
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancerEstrella Gonzales-Aloy, Aria Ahmed-Cox, Maria Tsoli, et al.
Psycho-Oncology|November 19, 2024
Second Opinion Seeking in Paediatric Oncology: Motivations and PredictorsStephen Kerras, Kate Hetherington, Sara Toofanian, et al.
Theranostics|July 14, 2022
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapyDannielle H Upton, Caitlin Ung, Sandra M George, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastomaJoanna Keating, Maria Tsoli, Andrew R Hallahan, et al.
Journal of Visualized Experiments : Jove|May 19, 2025
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic DeviceMaria Tsoli, Yongjuan Chen, Anjana Gopalakrishnan, et al.
Cancers|December 24, 2021
Therapeutic Targets in Diffuse Midline Gliomas-An Emerging LandscapeElisha Hayden, Holly Holliday, Rebecca Lehmann, et al.
Pediatric Nephrology (Berlin, Germany)|February 19, 2005
Retinoic acid may increase the risk of bone marrow transplant nephropathyLeigh Haysom, David S Ziegler, Richard J Cohn, et al.
Neuro-Oncology|January 31, 2006
Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumorsDavid S Ziegler, Richard J Cohn, Geoffrey McCowage, et al.
Pediatric Blood & Cancer|July 28, 2011
Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high-dose cyclophosphamide and peripheral stem cell support: an Australian and New Zealand Children's Hematology and Oncology Group studyGeoffrey B McCowage, Robert Mrongovius, Frank Alvaro, et al.
Neuro-Oncology Advances|March 29, 2024
Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomasYongjuan Chen, Aaminah Khan, Christopher Katsinas, et al.
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Advanced Drug Delivery Reviews|March 17, 2023
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancerEstrella Gonzales-Aloy, Aria Ahmed-Cox, Maria Tsoli, et al.
Psycho-Oncology|November 19, 2024
Second Opinion Seeking in Paediatric Oncology: Motivations and PredictorsStephen Kerras, Kate Hetherington, Sara Toofanian, et al.
Theranostics|July 14, 2022
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapyDannielle H Upton, Caitlin Ung, Sandra M George, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastomaJoanna Keating, Maria Tsoli, Andrew R Hallahan, et al.
Journal of Visualized Experiments : Jove|May 19, 2025
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic DeviceMaria Tsoli, Yongjuan Chen, Anjana Gopalakrishnan, et al.
Cancers|December 24, 2021
Therapeutic Targets in Diffuse Midline Gliomas-An Emerging LandscapeElisha Hayden, Holly Holliday, Rebecca Lehmann, et al.
Pediatric Nephrology (Berlin, Germany)|February 19, 2005
Retinoic acid may increase the risk of bone marrow transplant nephropathyLeigh Haysom, David S Ziegler, Richard J Cohn, et al.
Neuro-Oncology|January 31, 2006
Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumorsDavid S Ziegler, Richard J Cohn, Geoffrey McCowage, et al.
Pediatric Blood & Cancer|July 28, 2011
Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high-dose cyclophosphamide and peripheral stem cell support: an Australian and New Zealand Children's Hematology and Oncology Group studyGeoffrey B McCowage, Robert Mrongovius, Frank Alvaro, et al.
Neuro-Oncology Advances|March 29, 2024
Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomasYongjuan Chen, Aaminah Khan, Christopher Katsinas, et al.
Pageof 18